The American Society of Clinical Oncology and the Association for Clinical Oncology (collectively, ASCO) are multidisciplinary, global oncology organizations with nearly 45,000 members in over 150 countries. Through research, education, and promotion of the highest-quality, equitable patient care, members work to conquer cancer and create a world where cancer is prevented or cured, and every survivor is healthy. Our resources support oncology professionals at every stage of their career and across all patient care roles. Membership is free for all oncology trainees and students and is discounted for oncologists who practice in low- and middle- income countries.
Visit www.asco.org for further information.

The Canadian Global Cancer Network was formed to develop a collaborative national approach to global cancer control, to learn from professionals in the field, and to maximize the impact of collective efforts. The network aspires to improve equity and reduce disparities in cancer control globally through pan-Canadian collaboration. The Network will develop a national approach to global cancer control that fosters effective partnerships, strengthens capacity in cancer control systems, and positions cancer in the Canadian global health agenda.

.

ecancer is a charity based in the UK with the mission to raise the standards of care for cancer patients across the world through education. Because education saves lives.

We believe that receiving the best possible cancer care is a fundamental human right. However, all too often healthcare professionals come up against financial, linguistic and geographical barriers to accessing the highest quality knowledge about how to treat people with cancer.

We break down these barriers through ecancer.org, a platform with high-quality and free oncology education for the global oncology community. We have thousands of resources from doctors, nurses and other oncology professionals across the world sharing expertise on best clinical practice with their peers.

Videos. Journal. E-learning. Events.

As a leader in precision radiation therapy, Elekta is committed to ensuring every patient has access to the best cancer care possible. We openly collaborate with customers to advance sustainable, outcome-driven and cost-efficient solutions to meet evolving patient needs, improve lives and bring hope to everyone dealing with cancer. To us, it’s personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in more than 120 countries and listed on Nasdaq Stockholm.

Visit www.elekta.com for further information

Aligned with the World Health Organization’s (WHO) Global Strategy to accelerate the elimination of cervical cancer. the SUCCESS project – Scale Up Cervical Cancer Elimination with Secondary prevention Strategy – aims at screening 185,000 women, 40% of whom are living with HIV, in Burkina Faso, Côte d’Ivoire, Guatemala and the Philippines.
These four low- and middle-income countries are representative of resource-limited regions where more than 90% of the women who die from cervical cancer today are found. Moreover, women living with HIV are six times as likely to develop cervical cancer compared to women who are HIV negative.
SUCCESS, through its various activities, focuses on secondary prevention by introducing and expanding HPV screening within the screening and treatment of precancerous lesions. SUCCESS aims to build capacity in partner countries to improve coverage of cervical cancer control services by integrating secondary prevention services into both HIV services and reproductive health services. The project also engages in regional outreach with up to 20 countries through activities focusing on capacity building and health financing.
Funded by Unitaid, SUCCESS is implemented by Expertise France, with consortium partners including Jhpiego and the Union for International Cancer Control (UICC) and technical support partners including National Cancer Institutes of Brazil, France, Japan and USA.

Varian is the world’s leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Visit www.varian.com for more information.